CABINET APPROVES PRODUCTION LINKED INCENTIVE SCHEME FOR PHARMACEUTICALS #EDUCRATSWEB

  • Home
  • Jobs
  • Q&A
  • Register
  • Login
  • Search Business Directory
  • List Your Business for Free - Join Us & bring more customers

  • The Union Cabinet, chaired by the Prime Minister, Shri Narendra Modi has approved Production Linked Incentive (PLI) Scheme for Pharmaceuticals over a period of Financial Year 2020-21 to 2028-29.

    The Scheme will benefit domestic manufacturers, help in creating employment and is expected to contribute to the availability of wider range of affordable medicines for consumers.

    The scheme is expected to promote the production of high value products in the country and increase the value addition in exports.  Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28.

    The scheme is expected to generate employment for both skilled and un-skilled personnel, estimated at 20,000 direct and 80,000 indirect jobs as a result of growth in the sector.

    It is expected to promote innovation for development of complex and high-tech products including products of emerging therapies and in-vitro Diagnostic Devices as also self-reliance in important drugs.  It is also expected to improve accessibility and affordability of medical products including orphan drugs to the Indian population.  The Scheme is also expected to bring in investment of Rs.15,000 crore in the pharmaceutical sector.

    The scheme will be part of the umbrella scheme for the Development of Pharmaceutical Industry. The objective of the scheme is to enhance India's manufacturing capabilities by increasing investment and production in the sector and contributing to product diversification to high value goods in the pharmaceutical sector. One of the further objectives of the scheme is to create global champions out of India who have the potential to grow in size and scale using cutting edge technology and thereby penetrate the global value chains.

    The salient features of the Scheme are as follows:-

    Target Groups:

    The manufacturers of pharmaceutical goods registered in India will be grouped based on their Global Manufacturing Revenue (GMR) to ensure wider applicability of the scheme across the pharmaceutical industry and at the same time meetthe objectives of the scheme. The qualifying criteria for the three groups of applicants will be as follows-

     

    (a) Group A: Applicants having Global Manufacturing Revenue (FY 2019-20) of pharmaceutical goods more than or equal to Rs 5,000 crore.

    (b) Group B: Applicants having Global Manufacturing Revenue (FY 2019-20) of pharmaceutical goods between Rs 500 (inclusive) crore and Rs 5,000 crore.

    (c) Group C: Applicants having Global Manufacturing Revenue (FY 2019-20) of pharmaceutical goods less than Rs 500 crore. A sub-group for MSME industry will be made within this group, given their specific challenges and circumstances.

     

    Quantum of Incentive:

    The total quantum of incentive (inclusive of administrative expenditure) under the scheme is about Rs 15,000 crore. The incentive allocation among the Target Groups is as follows:

    (a)          Group A: Rs 11,000 crore.

    (b)          Group B: Rs 2,250 crore.

    (c)           Group C: Rs 1,750 crore.

     

    The incentive allocation for Group A and Group C applicants shall not be moved to any-other category. However, incentive allocated to Group B applicants, if left underutilized can be moved to Group A applicants.

    Financial Year 2019-20 shall be treated as the base year for computation of incremental sales of manufactured goods.

    Category of Goods:

    The scheme shall cover pharmaceutical goods under three  categories as mentioned below:

    1. Category 1

    Biopharmaceuticals; Complex generic drugs; Patented drugs or drugs nearing patent expiry; Cell based or gene therapy drugs; Orphan drugs; Special emptycapsules like HPMC, Pullulan, enteric etc.; Complex excipients; Phyto-pharmaceuticals: Otherdrugs as approved.

    (b)Category 2

    Active Pharmaceutical Ingredients / Key Starting Materials / Drug Intermediates.

    (c)Category 3 (Drugs not covered under Category 1 and Category 2)

    Repurposed drugs; Auto immune drugs, anti-cancer drugs, anti-diabetic drugs, anti-infective drugs, cardiovascular drugs, psychotropic drugs and anti-retroviral drugs; In vitro diagnostic devices; Other drugs as approved; Other drugs not manufactured in India.

     

    Rate of incentive will be 10% (of incremental sales value) for Category 1 and Category 2 products for first four years, 8% for the fifth year and 6% for the sixth year of production under the scheme.

    Rate of incentive will be 5% (of incremental sales value) for Category 3 products for first four years, 4% for the fifth year and 3% for the sixth year of production under the scheme.

    The duration of the scheme will be from FY 2020-21 to FY 2028-29. This will include the period for processing of applications (FY 2020-21), optional gestation period of one year (FY 2021-22), incentive for 6 years and FY 2028-29 for disbursal of incentive for sales of FY 2027-28.

    Background:

    Indian pharmaceutical industry is 3rd largest in the world by volume and is worth USD 40 billion in terms of value. The country contributes 3.5% of total drugs and medicines exported globally. India exports pharmaceuticals to more than 200 countries and territories including highly regulated markets such as USA, UK, European Union, Canada etc. India has a complete ecosystem for the development and manufacturing of pharmaceuticals with companies having state of the art facilities and highly skilled/technical manpower. The country also has a number of renowned pharmaceutical educational and research institutes and a robust support of allied industries.

    At present, low value generic drugs account for the major component of Indian exports, while a large proportion of the domestic demand for patented drugs is met through imports. This is because the Indian Pharmaceutical sector lacks in high value production along with the necessary pharma R&D. In order to incentivize the global and domestic players to enhance investment and production in diversified product categories, a well-designed and suitably targeted intervention is required to incentivise specific high value goods such as bio-pharmaceuticals, complex generic drugs, patented drugs or drugs nearing patent expiry and cell based or gene therapy products etc.

    https://www.pib.gov.in/PressReleasePage.aspx?PRID=1700434

    Cabinet approves Production Linked Incentive Scheme for Pharmaceuticals
    We would love to hear your thoughts, concerns or problems with anything so we can improve our website educratsweb.com ! email us at educratsweb@gmail.com and submit your valuable feedback.
    Save this page as PDF | Recommend to your Friends

    JOIN OUR TELEGRAM DISCUSSION GROUP | SUBSCRIBE TO OUR NEWSLETTER
    April 20 - Historical Events - On This Day
    Subh Mangalwar (Tuesday)  IMAGES, GIF, ANIMATED GIF, WALLPAPER, STICKER FOR WHATSAPP & FACEBOOK
    Subh Mangalwar (Tuesday)

    Recent Posts

    1. Shri Piyush Goyal launches the Startup India Seed Fund Scheme
    Minister of Railways, Commerce & Industry, Consumer Affairs and Food & Public Distribution Shri PiyushGoyal today launched the Startup India Seed Fund Scheme (SISFS). The Fund aims to provide financial assistance to startups for proof of concept, prototype development, product trials, market entry, and commerci
    2. Home Library Scheme
    Concession to Member of the Home Library Scheme: The Division will provide a discount of 20% on the books purchased by the members of the scheme, The minimum order under the scheme will be Rs.100/- after discount. The postage on dispatch on the publications will be borne by the Publications Division i.e. Free of cost. The members will re
    3. PM-KISAN Scheme
    PM-KISAN Scheme PM Kisan is a Central Sector scheme with 100% funding from Government of India. It has become operational from 1.12.2018. Under the scheme an income support of 6,000/- per year in three equal installments will be provided to small and marginal farmer families having combined land holding/ownership of upto 2 hectares. Definition of family for the scheme is husband, wife and minor children. State Government and UT administration
    4. Pradhan Mantri Jan Dhan Yojana (PMJDY) & Others Financial Scheme ...
    Pradhan Mantri Jan Dhan Yojana (PMJDY) Hon’ble Prime Minister announced Pradhan Mantri Jan Dhan Yojana as the National Mission on Financial Inclusion in his Independence Day address on 15th August 2014, to ensure comprehensive financial inclusion
    5. All India Agarbathi Manufacturers Association (AIAMA) to partner with Tripura Bamboo Mission for Bambusa Tulda production
    All India Agarbathi Manufacturers Association (AIAMA) to partner with Tripura Bamboo Mission for Bambusa Tulda production AIAMA to partner with Tripura Bamboo Mission for Bambusa Tulda production Deliberates and share suggestions to improve the bamboo sourcing and A
    6. Partial Credit Guarantee Scheme (PCGS) 2.0 extended with greater flexibility to respond to emerging demands
    As part of Aatmanirbhar Bharat Abhiyan, announced by the Government, Partial Credit Guarantee Scheme (PCGS) 2.0   was launched on 20.05.2020 to provide Portfolio Guarantee for purchase of Bonds or Commercial Papers (CPs) with a rating of AA and below issued by NBFCs/HFCs/ MFIs by Public Sector Banks (PSBs). It was envisaged to purchase Bonds/ CPs of Rs. 45,000 crore under PCGS 2.0 of which the maximum headroom permissible for purchase of Bonds/ CPs rated AA/AA-
    7. SAI approves Coaching Camp for Core Olympic Probables; Opens Karni Singh Shooting Range for national squad shooters
    The Sports Authority of India has approved the request for training facilities at the Karni Singh Shooting Range for national squad shooters with effect from 05 Oct 2020. 64 additional shooters would be provided ammunition and target on Govt expense. The SAI had already opened up the Dr Karni Singh Shooting Range (KSSR) in New Delhi for the NRAI core group as well as the developmental group and Khelo India shooters. SAI also understands the requirement of a dedicated camp for shooters
    8. Cabinet approves Haryana Orbital Rail Corridor Project from Palwal to Sonipat via Sohna-Manesar- Kharkhauda
    The Cabinet Committee on Economic Affairs, chaired by Prime Minister Shri Narendra Modi, has given its approval to the Haryana Orbital Rail Corridor Project from Palwal to Sonipat via Sohna-Manesar-Kharkhauda.  This Rail Line will start from Palwal and end at existing Harsana Kalan station (On Delhi-Ambala section).  This will also give connectivity enroute to existing Patli Station (On Delhi-Rewari line), Sultanpur station (On Garhi Harsaru-Farukhnagar Line) and Asaudha Station (On D
    9. Incentives for ASHAs
    The Ministry of Health & Family Welfare, Govt. of India has provisioned  additional incentive of Rs. 1000 per month under the “India COVID 19 Emergency Response and Health Systems Preparedness Package” to ASHAs for undertaking COVID 19 related activities for the period of their engagement in this work. Further the benefit under “Pradhan Mantri Garib Kalyan Package : Insurance Scheme for Health Workers Fighting COVID 19”, has been launched  to provide an insurance cov
    10. New Healthcare Scheme for Covid-19 Victims
    There is provision made under ‘Pradhan Mantri Garib Kalyan Package for Health Workers Fighting COVID-19. This is a Central Sector scheme.   The scheme provide an insurance cover of Rs. 50 lakh to healthcare providers, including community health workers, who may have to be in direct contact and care of COVID-19 patients and who may be at risk of being impacted by this. It will also include accidental loss of life on account of contracting COVID-19.  
    11 Piyush Vedprakash Goyal - (Born 13 June 1964) is an Indian politician and the current minister of Railways and Commerce in the Government of India. He was elevated to the Cabinet Minister position on 3 September 2017. He is currently a Member of Parliament for Rajya Sabha from the state of Maharashtra, and the Deputy Leader of Rajya Sabha. He was earlier the National Treasurer of the Bharatiya Janata Party (BJP). He headed the BJP Information Communication Campaign Committee and oversaw the publicity and advertising campaign of the party including the social media outreach for the Indian General Elections 2014. Goyal is the 2018 Carnot Prize Recipient for distinguished contributions to energy policy. Piyush Goyal has been allocated the cabinet ministry for Narendra Modi led NDA government in May 2019. He is currently taking charge as Minister of Railways and Minister of Commerce and Industry.
    12 प्रधानमंत्री आवास योजना (शहरी) ऋण आधारित ब्याज सब्सिडी (Credit Linked Subsidy Scheme-CLSS) #BiharUrbanDevelopmentAndHousingDept
    13 Pradhan Mantri Garib Kalyan Package : Insurance Scheme for Health Workers Fighting COVID-19
    Follow us on Twitter  IMAGES, GIF, ANIMATED GIF, WALLPAPER, STICKER FOR WHATSAPP & FACEBOOK Follow us on Twitter

    Jobs & Career Engineering Faculty & Teaching Defense & Police UPSC Scholorship Railway IT & Computer SSC Clerk & Steno UGC NET
    Contents News Education General Awareness Government Schemes Admit Card Study Material Exam Result Scholorship DATA Syllabus Contact us
    Explore more Archives Web Archive Register / Login Rss feed Posts Free Online Practice Set Useful Links / Sitemap Photo / Video Search Pincode Best Deal Greetings Recent Jobs Guest Contributor educratsweb Latest Jobs Notification sarkariniyukti.blogspot.com Bharatpages - BUSINESS DIRECTORY IN INDIA - FREE ONLINE BUSINESS LISTING
    Our Blog Educratsweb Blog Bhakti Sangam chitragupta ji maharaj shri shirdi sai baba sansthan
    Follow my blog with Bloglovin


    Guest Post | Submit   Job information   Contents   RSS feed   Link   Youtube Video   Photo   Register with us Register login Login
    Bengali English Gujarati Hindi Kannada Punjabi Tamil Telugu Urdu or Any other Language Google's cache Page
    educratsweb logo
    educratsweb provide the educational contents, Job, Online Practice set for students.
    if you have any information regarding Job, Study Material or any other information related to career. you can Post your article on our website. Click here to Register & Share your contents.
    For Advertisment email us at educratsweb@gmail.com
    #Search | http://educratsweb.com/content.php?id=5394&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+educratsweb+%28educratsweb.com%29